Tianjin Zhong Xin Pharmaceutical Group Corporation Limited is a large pharmaceutical Enterprise with investment and holding functions . It is the sole listed Chinese company by holding both S-shares in Singapore and A-shares in China. ZhongXin Pharm.products have long famous history all over the world. In 2003, ZhongXin Chemical Technology Center (ZXCTC) was ceremoniously established.
ZXCTC is located in ZhongXin Pharm., Tianjin XINXIN pharmaceutical Manufactory. The factory has bulk drug manufacture experiences of more than 40 years. The factory passed National GMP inspection, parts of products passed FDA and COS inspection. ZXCTC is dedicated to chemical pharmaceutical R&D, plant trial and bulk operation plus outsourcing manufacture for customers (New intermediates and small quantities of products). ZXCTC is leading by a post-doctoral, who had more than 20 years pharmaceutical /fine chemical experience in international companies, with independent and advanced management system. ZXCTC is formed by systhesis, analysis , dosage form, plant trial, large scale operation, marketing & sales and other related functional departments.
Two Anti-virus drugs (LAMIVUDINE and EMTRICITABINE ) and their intermediates are already on the market. With the best quality and competitive price, our LAMIVUDINE operation line has been in full capacity – More than 100 tons per year and we are absolutely the biggest operation in China. We would like to expand our current line to 200 tons per year in order to meet our customer requirement. Emtricitabine , the new generation of Anti-virus drug and its intermediates ( FCME ) is also in operation with highest quality and competitive price. Some other anti-virus drugs ( Tenofovir and Adfovir ) and Ondanstron are either in Plant trial or late development. Our goal is to provide the highest product quality with most competitive cost for the benefits of all our customers in the world.
|
